Skip to main content

Table 2 Treatment Efficacy in CML-CP by Regimen

From: Summary of 615 patients of chronic myeloid leukemia in Shanghai from 2001 to 2006

 

HU

IFN(+Ara-C)

Imatinib

HSCT

 

n = 70(%)

n = 184(%)

n = 154(%)

n = 21(%)

CHR n(%)

44(62.9)

139(75.5)

142(92.2)

17(81.0)

MCyR n(%)

0

37(20.1)

116(75.3)

15(71.4)

CCyR n(%)

0

29(15.8)

99(64.3)

15(71.4)

ND

47(67.1)

43(23.4)

5(3.2)

0

  1. CHR = complete hematologic response, MCyR = major cytogenetic response, CCyR = complete cytogenetic response.
  2. aND: without examination during the treatment.